Publisher Summary A dithiothreitol (DTT)-insensitive cholinephosphotransferase catalyzes the transfer of phosphocholine from CDPcholine to l-alkyl-2-acetyl- sn -glycerol in the final step of the biosynthesis of platelet-activating factor (PAF) in the de novo pathway. In contrast, DTT strongly inhibits the cholinephosphotransferase activity that catalyzes the formation of phosphatidylcholine from diacylglycerols and CDPcholine. Therefore, the terms DTT-insensitive and DTT-sensitive are useful in distinguishing these two types of cholinephosphotransferases. Because the two types of cholinephosphotransferase activities differ in a number of other properties, different proteins might be responsible for synthesizing PAF and phosphatidylcholine. The importance of the DTT-insensitive cholinephosphotransferase in maintaining PAF at physiological is significant because the cosubstrate (CDPcholine) formed by cytidylyltransferase can be rate limiting in the synthesis of PAF by the de novo route. Yet, an additional function of the DTT-insensitive cholinephosphotransferase could be its regulation of the cellular levels of alkylacetylglycerols, because the latter can also induce biological responses by influencing protein kinase C activity and by inducing cell differentiation (for example, converting HL-60 cells to macrophage-like cells7). The DTT-insensitive cholinephosphotransferase occupies a central position in the PAF de novo pathway because it can utilize one type of mediator (alkylacetylglycerols) as a substrate to produce another (PAF) with completely different activities.